Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients

Hematology
Zeynep Arzu YeginÖzlem Karacaoğlu

Abstract

Objectives: T-cell immunoglobulin and mucin domain-containing protein-3 (TIM-3) is considered as a negative regulator of T-cell driven immune response. This study is planned to investigate the prognostic role of pre-transplant soluble TIM-3 (sTIM-3) levels in allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients. Methods: Pre-transplant serum sTIM-3 levels were measured in 177 allo-HSCT recipients [median age: 36(16-66) years; male/female: 111/66]. Results: Pre-transplant sTIM-3 levels were significantly higher in acute myeloid leukemia (AML) patients compared to acute lymphoblastic leukemia (ALL) patients (p = 0.01). Pre-transplant sTIM-3 levels were significantly lower in patients with abnormal cytogenetics (p = 0.017). Pre-transplant sTIM-3 levels were significantly higher in patients who developed viral hemorrhagic cystitis (p = 0.034). A positive correlation was demonstrated between sTIM-3 levels and acute graft versus host disease (GvHD) grade (p = 0.013; r = 0.299). Overall survival (OS) was not statistically different between low- and high-TIM-3 groups (%35.2 vs %20.4; p > 0.05). Primary diagnosis (p = 0.042), sinusoidal obstruction syndrome (p < 0.001), acute GvHD (p = 0.001), chronic GvHD (p = 0.00...Continue Reading

References

Dec 13, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Alexandra H FilipovichMary E D Flowers
Nov 30, 2010·Cell Stem Cell·Yoshikane KikushigeKoichi Akashi
Jan 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of Americaa
Mar 8, 2012·Bone Marrow Transplantation·N S MajhailUNKNOWN Sociedade Brasileira de Transplante de Medula Ossea
Aug 21, 2012·Annals of the New York Academy of Sciences·Yoshikane Kikushige, Koichi Akashi
Jun 25, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·John A HansenGeorge B McDonald
Dec 23, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Madan H JagasiaMary E D Flowers
Feb 28, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marta StanzaniGiuseppe Battista
May 20, 2015·Current Drug Targets·Hanna A KnausIvana Gojo
Jul 2, 2016·Haematologica·Jan StyczynskiUNKNOWN Sixth European Conference on Infections in Leukemia, a joint venture of the Infectious Diseases Working Party of the Europea
Jul 6, 2016·Frontiers in Immunology·Ranferi Ocaña-GuzmanIsabel Sada-Ovalle
Nov 22, 2016·Journal of Thrombosis and Haemostasis : JTH·M ScullyUNKNOWN International Working Group for Thrombotic Thrombocytopenic Purpura
Nov 24, 2016·The Journal of Antimicrobial Chemotherapy·Johan A MaertensPatricia Muñoz
Mar 5, 2017·Immunological Reviews·Madhumita DasVijay K Kuchroo
Mar 17, 2017·International Journal of Molecular Sciences·Wenwen DuBinfeng Lu
May 2, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas LehrnbecherLillian Sung
May 10, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·George B McDonaldJohn A Hansen
May 10, 2017·Journal of Hematology & Oncology·Chi Young Ok, Ken H Young
Dec 7, 2017·International Journal of Molecular Sciences·Robert J TorphyYuwen Zhu
Jan 24, 2018·Immunology and Cell Biology·Varun Sasidharan Nair, Eyad Elkord
Mar 16, 2018·Future Oncology·Amanda PrzespolewskiEunice S Wang
Mar 17, 2018·Journal of Hematology & Oncology·Julian A Marin-AcevedoYanyan Lou
Mar 22, 2018·F1000Research·Hridesh Banerjee, Lawrence P Kane
May 3, 2019·AIDS·Eva ZilberUNKNOWN CHERUB Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

The Journal of Immunology : Official Journal of the American Association of Immunologists
Hui GengZuo-Hua Feng
The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Tracy B GrossmanSteven S Witkin
© 2021 Meta ULC. All rights reserved